Related Experiment Videos
Summary
Cholecystokinin (CCK) release in the rat brain is modulated by dopamine receptors. Dopamine agonists can enhance or attenuate CCK release, suggesting complex interactions in neurotransmission.
Area of Science:
- Neuroscience
- Neurochemistry
- Molecular Biology
Background:
- Cholecystokinin (CCK) peptides, particularly CCK8, are found in brain regions like the rat neostriatum (caudate-putamen).
- High concentrations in axons and nerve endings suggest a potential neurotransmitter role for CCK in this area.
Purpose of the Study:
- To investigate the release of cholecystokinin-immunoreactivity (CCK-IR) from rat caudate-putamen slices in vitro.
- To determine the modulatory effects of dopaminergic agonists on CCK-IR release.
Main Methods:
- Incubation of rat caudate-putamen (CP) slices.
- Induction of CCK-IR release using veratridine.
- Assessment of Ca2+ dependency and tetrodotoxin blockade of release.
- Application of dopaminergic agonists to study receptor-mediated modulation.
Main Results:
- Veratridine induced Ca2+-dependent and tetrodotoxin-sensitive release of CCK-IR.
- Dopaminergic agonists differentially modulated veratridine-induced CCK-IR release.
- Enhancement of release was mediated by receptors on afferent axons, possibly D-2 subtype.
- Attenuation of release involved receptors intrinsic to CP, likely D-1 subtype coupled to adenylate cyclase.
- Endogenous dopamine release was found to enhance CCK-IR secretion.
Conclusions:
- Dopaminergic agonists modulate CCK-IR release in the rat caudate-putamen via distinct receptor subtypes.
- D-2 receptors on afferent terminals and D-1 receptors on intrinsic neurons play roles in regulating CCK release.
- These findings highlight a complex interplay between dopamine and cholecystokinin signaling in the neostriatum.